Hypertension, Statin Use Increased for Individuals Using TAF for PrEP
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Sept. 14, 2023 -- For individuals taking preexposure prophylaxis (PrEP) for preventing HIV infection, tenofovir alafenamide fumarate (TAF) use is associated with higher incident hypertension and statin initiation compared with tenofovir disoproxil fumarate (TDF) use, according to a study published online Sept. 11 in JAMA Network Open.
Adovich S. Rivera, M.D., Ph.D., from Kaiser Permanente Southern California in Pasadena, and colleagues examined the risk for incident hypertension and statin initiation among adult health plan members initiating PrEP with TAF versus TDF in a retrospective cohort study. Propensity score matching was conducted to generate matched data sets (1:4 TAF:TDF) with balanced baseline covariates.
Data were included for 6,824 eligible individuals. Two cohorts were generated without baseline hypertension or statin use for matching: 5,523 for hypertension and 6,149 for statin. The researchers found that in a matched analysis adjusted for baseline covariates, the risk for incident hypertension was elevated in association with TAF use (odds ratio, 1.64). An elevated risk for statin initiation was also seen in association with TAF use (odds ratio, 2.33). Similar results with a larger risk difference in statin initiation were seen in a subgroup analysis restricted to individuals aged 40 years and older at PrEP initiation (odds ratio, 3.05).
"TAF has been a welcome addition to the products for PrEP due to its benefits on kidney and bone health and smaller pill size," the authors write. "However, it may have unwanted impact on cardiometabolic health."
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Cognitive Impairment Still Seen in Children, Teens With HIV
TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...
Pandemic Reignited Debate Regarding Physician's Obligation to Treat
MONDAY, April 29, 2024 -- There was a surge in ethics literature during COVID-19 advocating for the ethical acceptability of physicians refusing to treat, according to a study...
Coronary Artery Vessel Wall Thickness Increased for People Living With HIV
TUESDAY, April 16, 2024 -- Asymptomatic people living with HIV (PLWH) with a low risk for cardiovascular disease have increased coronary artery vessel wall thickness (VWT)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.